Works matching AU Byoung-Gie Kim


Results: 138
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021).

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 1, p. 195, doi. 10.4143/crt.2016.376
    By:
    • Shin-Wha Lee;
    • Yong-Man Kim;
    • Chi Heum Cho;
    • Young Tae Kim;
    • Seok Mo Kim;
    • Soo Young Hur;
    • Jae-Hoon Kim;
    • Byoung-Gie Kim;
    • Seung-Cheol Kim;
    • Hee-Sug Ryu;
    • Soon Beom Kang
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041).

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3188, doi. 10.3390/cancers12113188
    By:
    • Choi, Min Chul;
    • Kim, Yong-Man;
    • Lee, Jeong-Won;
    • Lee, Yong Jae;
    • Suh, Dong Hoon;
    • Lee, Sung Jong;
    • Lee, Taek Sang;
    • Lee, Maria;
    • Park, Dong Choon;
    • Kim, Min Kyu;
    • Lee, Jong-Min;
    • Shim, Seung-Hyuk;
    • Jeon, Seob;
    • Min, Kyung Jin;
    • Kim, Mi Kyung;
    • Kim, Bo Wook;
    • Park, Jeong Yeol;
    • Kim, Byoung-Gie;
    • Kim, Dae Yeon;
    • Kim, Moon-Hong
    Publication type:
    Article
    22
    23
    24
    25

    Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer.

    Published in:
    British Journal of Cancer, 2018, v. 119, n. 5, p. 530, doi. 10.1038/s41416-018-0206-7
    By:
    • Aoki, Yoichi;
    • Ochiai, Kazunori;
    • Lim, Soyi;
    • Aoki, Daisuke;
    • Kamiura, Shoji;
    • Lin, Hao;
    • Katsumata, Noriyuki;
    • Cha, Soon-Do;
    • Kim, Jae-Hoon;
    • Kim, Byoung-Gie;
    • Hirashima, Yasuyuki;
    • Fujiwara, Keiichi;
    • Kim, Young-Tak;
    • Kim, Seok Mo;
    • Chung, Hyun Hoon;
    • Chang, Ting-Chang;
    • Kamura, Toshiharu;
    • Takizawa, Ken;
    • Takeuchi, Masahiro;
    • Kang, Soon-Beom
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-OV80).

    Published in:
    Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e51
    By:
    • Jung-Yun Lee;
    • Tan, David;
    • Ray-Coquard, Isabelle;
    • Jung Bok Lee;
    • Byoung Gie Kim;
    • Van Nieuwenhuysen, Els;
    • Yun-Ju Huang, Ruby;
    • Ka Yu Tse;
    • González-Martin, Antonio;
    • Scott, Clare;
    • Hasegawa, Kosei;
    • Wilkinson, Katie;
    • Eun Yeong Yang;
    • Lheureux, Stephanie;
    • Kristeleit, Rebecca
    Publication type:
    Article
    39
    40
    41

    DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, p. 19, doi. 10.3802/jgo.2024.35.S2.P1
    By:
    • Chel Hun Choi;
    • Ray-Coquard, Isabelle;
    • Rubio, Maria Jesus;
    • Paoletti, Xavier;
    • Hudson, Emma;
    • Lorusso, Domenica;
    • Hasler-Strub, Ursula;
    • Vardar, Mehmet Ali;
    • Lheureux, Stéphanie;
    • Van Gorp, Toon;
    • Shao Peng Tan, David;
    • Trillsch, Fabian;
    • Eberst, Lauriane;
    • Lescure, Céline;
    • Hardy-Bessard, Anne-Claire;
    • Chaix, Marie;
    • Byoung-Gie Kim;
    • JaeWeon Kim;
    • JeongYeol Park;
    • Jung-Yun Lee
    Publication type:
    Article
    42

    Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e40
    By:
    • Kan Yonemori;
    • Keiichi Fujiwara;
    • Kosei Hasegawa;
    • Mayu Yunokawa;
    • Kimio Ushijima;
    • Shiro Suzuki;
    • Ayumi Shikama;
    • Shinichiro Minobe;
    • Tomoka Usami;
    • Jae-Weon Kim;
    • Byoung-Gie Kim;
    • Peng-Hui Wang;
    • Ting-Chang Chang;
    • Keiko Yamamoto;
    • Shirong Han;
    • McKenzie, Jodi;
    • Orlowski, Robert J.;
    • Takuma Miura;
    • Makker, Vicky;
    • Yong Man Kim
    Publication type:
    Article
    43
    44

    Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan.

    Published in:
    Journal of Gynecologic Oncology, 2023, v. 34, n. 1, p. 1, doi. 10.3802/jgo.2023.34.e3
    By:
    • Hung-Hsueh Chou;
    • Fereday, Sian;
    • DeFazio, Anna;
    • Chih-Long Chang;
    • Bowtell, David;
    • Heng-Cheng Hsu;
    • Traficante, Nadia;
    • Soo Young Jeong;
    • Wen-Fang Cheng;
    • Ariyarantne, Dinuka;
    • Teresa Tung;
    • Rajadhyaksha, Viraj;
    • Won-Hee Lee;
    • Brown, David;
    • Byoung-Gie Kim
    Publication type:
    Article
    45
    46
    47
    48
    49
    50